Skip to content

Clinical trials

Phase 1 Ovarian Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1 Country / region: France Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20111
20131
20141
20163
20175
20181
20193
20202
20213
20223
20232
20246
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting10
Recruiting8
Terminated6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Eli Lilly and Company4
AstraZeneca2
Novartis Pharmaceuticals2
Seagen Inc.2
Alterome Therapeutics, Inc.1
Assistance Publique - Hôpitaux de Paris1
Atavistik Bio, Inc1
Boehringer Ingelheim1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms37
Carcinoma, Non-Small-Cell Lung20
Triple Negative Breast Neoplasms14
Endometrial Neoplasms12
Uterine Cervical Neoplasms12
Colorectal Neoplasms11
Neoplasms11
Stomach Neoplasms11
Squamous Cell Carcinoma of Head and Neck10
Esophageal Neoplasms9

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.